Charles Schwab Investment Management Inc. boosted its position in TriMas Co. (NASDAQ:TRS - Free Report) by 3.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 605,502 shares of the industrial products company's stock after purchasing an additional 22,656 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.49% of TriMas worth $14,889,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in TRS. Intech Investment Management LLC purchased a new position in shares of TriMas during the 3rd quarter worth $269,000. FMR LLC lifted its position in TriMas by 1.7% during the third quarter. FMR LLC now owns 44,082 shares of the industrial products company's stock worth $1,125,000 after buying an additional 729 shares during the period. Paloma Partners Management Co acquired a new stake in TriMas in the 3rd quarter worth about $293,000. Barington Capital Group L.P. grew its holdings in TriMas by 4.3% in the 3rd quarter. Barington Capital Group L.P. now owns 608,000 shares of the industrial products company's stock valued at $15,522,000 after buying an additional 25,000 shares during the period. Finally, Atom Investors LP increased its stake in shares of TriMas by 62.0% during the 3rd quarter. Atom Investors LP now owns 179,328 shares of the industrial products company's stock valued at $4,578,000 after acquiring an additional 68,608 shares during the last quarter. 99.42% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, BWS Financial reissued a "buy" rating and issued a $40.00 target price on shares of TriMas in a research report on Friday, February 28th.
Read Our Latest Report on TRS
Insider Transactions at TriMas
In related news, Director Shawn Sedaghat acquired 554,149 shares of the business's stock in a transaction on Monday, March 10th. The shares were bought at an average cost of $24.07 per share, with a total value of $13,338,366.43. Following the completion of the transaction, the director now directly owns 900,974 shares of the company's stock, valued at $21,686,444.18. This trade represents a 159.78 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeffrey A. Fielkow bought 2,500 shares of the firm's stock in a transaction dated Friday, February 28th. The stock was bought at an average cost of $20.78 per share, with a total value of $51,950.00. Following the transaction, the director now directly owns 11,013 shares of the company's stock, valued at approximately $228,850.14. This trade represents a 29.37 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 806,246 shares of company stock worth $19,338,213 in the last three months. 1.10% of the stock is currently owned by company insiders.
TriMas Trading Down 2.6 %
Shares of TRS stock traded down $0.63 on Monday, reaching $23.62. 414,206 shares of the stock were exchanged, compared to its average volume of 283,446. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60. The stock has a market cap of $958.57 million, a P/E ratio of 36.91 and a beta of 0.65. The firm has a 50 day moving average of $23.77 and a two-hundred day moving average of $25.04. TriMas Co. has a 1-year low of $19.33 and a 1-year high of $28.51.
TriMas Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 28th were issued a $0.04 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.68%. TriMas's dividend payout ratio (DPR) is 27.12%.
TriMas Company Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Articles

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.